发明名称 INDAZOLE DERIVATIVES WITH 5-HT2 RECEPTOR ACTIVITY________________
摘要 A chemical compound of formula (I) wherein R1 to R3 are independently selected from hydrogen and alkyl; R4 to R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, amino, monoalkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, arylthio, arylsulfoxyl, arylsulfonyl, alkylsulfoxyl, alkylsulfonyl, nitro, cyano, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino, aminocarbonyloxy, monoalkylaminocarbonyloxy, dialkylaminocarbonyloxy, monoalkylaminocarbonylamino and dialkylaminocarbonylamino; and R8 is selected from alkyl and alkoxy, and pharmaceutically acceptable salts and prodrugs thereof, and the use thereof in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity.
申请公布号 WO0012481(A3) 申请公布日期 2000.06.08
申请号 WO1999GB02875 申请日期 1999.09.01
申请人 CEREBRUS PHARMACEUTICALS LIMITED;ADAMS, DAVID, REGINALD;BENTLEY, JONATHAN, MARK;ROFFEY, JONATHAN, RICHARD, ANTHONY;HAMLYN, RICHARD, JOHN;GEORGE, ASHLEY, ROGER 发明人 ADAMS, DAVID, REGINALD;BENTLEY, JONATHAN, MARK;ROFFEY, JONATHAN, RICHARD, ANTHONY;HAMLYN, RICHARD, JOHN;GEORGE, ASHLEY, ROGER
分类号 A61K31/416;A61P1/00;A61P3/04;A61P7/02;A61P9/00;A61P13/00;A61P25/00;A61P25/06;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P43/00;C07D231/56;(IPC1-7):C07D231/56 主分类号 A61K31/416
代理机构 代理人
主权项
地址